Keywords: UK, NICE, Pierre Fabre, Javlor Bladder cancer, Pricing

UK’s NICE gives initial thumbs down to Pierre Fabre’s Javlor for bladder cancer on the NHS

Article | 24 November 2010

Print This

In preliminary draft guidance issued for public consultation yesterday, the UK’s National Institute for Health and Clinical Excellence ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in